BNTX

BioNTech
BNTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$24.96B
EV
$7.84B
Shares Outstanding
240.13M
Beta
1.08

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$140.71
P/E 2025E
-
P/Revenue 2025E
10.35x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioNTech SE

gainify
BNTX

BioNTech SE

BNTX

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is ...

Sector

Healthcare

Industry

Biotechnology

CEO

Sahin, Ugur

Employees

6,772

IPO Date

2019-10-10

Headquarters

An der Goldgrube 12, Mainz, Rhineland-Palatinate, 55131, Germany

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved